Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors

Cell

Volumn 91, Issue 1, 1997, Pages 119-126

  Söderberg Nauclér, Cecilia ^a,b   Fish, Kenneth N ^a   Nelson, Jay A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CELL MARKER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLOGENEIC RESTRICTION; ARTICLE; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; PRIORITY JOURNAL; VIRUS CULTURE; VIRUS REACTIVATION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0242421666     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(01)80014-3     Document Type: Article

References (59)

1. Adams, D., and Hamilton, T.A. (1992). Molecular basis of macrophage activation: diversity and its origin. In The Macrophage, C. Lewis, J.O. McGee, eds. (Oxford: Oxford University Press), pp. 77-115.
2. Boström, L., Ringdén, O., Gratama, J.W., Jacobsen, N., Prentice, H.G., Zwaan, F.E., and Nilsson, B. (1990). A role of herpes virus serology for the development of acute graft-versus-host disease. Leukemia working party of the European group for bone marrow transplantation. Bone Marrow Transpl. 5, 321-326.
3. Britt, W.J., and Alford, C.A. (1996). Cytomegalovirus. In Fields Virology, B.N. Fields, D.M. Knipe, P.M. Howley, eds. (Philadelphia: Lippincott-Raven Publishers), pp. 2493-2523.
4. Britt, W.J., and Vugler, L.G. (1992). Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116). J. Virol. 66, 6747-6754.
5. Bruning, J.H., Bruggeman, C.A., van Boven, C.P., and van Breda Vriesman, P.J. (1986). Passive transfer of cytomegalovirus by cardiac and renal organ transplants in a rat model. Transplantation 41, 695-698.
6. Brytting, M., Mousavi-Jazi, M., Bostrom, L., Larsson, M., Lunderberg, J., Ljungman, P., Ringden, O., and Sundqvist, V.A. (1995). Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients. Transplantation 60, 961-965.
7. Caux, C., Vanbervliet, B., Massacrier, C., Dezutter-Dambuyant, C., de Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., and Banchereau, J. (1996). CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J. Exp. Med. 184, 695-706.
8. Chou, S.W. (1986). Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. N. Engl. J. Med. 314, 1418-1423.
9. Döcke, W.D., Prösch, S., Fietze, E., Kimel, V., Zuckermann, H., Klug, C., Syrbe, U., Kruger, D.H., von Baehr, R., Volk, H.D. (1994). Cytomegalovirus reactivation and tumor necrosis factor. Lancet 343, 268-269.
10. Fish, K.N., Depto, A.S., Moses, A.V., Britt, W., and Nelson, J.A. (1995). Growth kinetics of human cytomegalovirus are altered in monocytederived macrophages. J. Virol. 69, 3737-3743.
11. Fish, K.N., Britt W., and Nelson, J.A. (1996). A novel mechanism for persistence of human cytomegalovirus in macrophages. J. Virol. 70, 1855-1862.
12. Fleckenstein, B., Muller, I., and Collins, J. (1982). Cloning of the complete human cytomegalovirus genome in cosmids. Gene 18, 39-46.
13. Gendelman, H.E., Orenstein, J.M., Martin, M.A., Ferrua, C., Mitra, R., Phipps, T., Wahl, L.A., Lane, H.C., Fauci, H.C., Burke, D.E., et al. (1988). Efficient isolation and propagation of human immunodeficiency virus on rCSF-1 treated monocytes. J. Exp. Med. 167, 1428-1441.
14. Gnann, J., Jr., Ahlmen, J., Svalander, C., Olding, L., Oldstone, M.B., and Nelson, J.A. (1988). Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am. J. Pathol. 132, 239-248.
15. Grattan, M.T., Moreno-Cabral, C.E., Starnes, V.A., Oyer, P.E., Stinson, E.B., and Shumway, N.E. (1989). Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261, 3561-3566.
16. Hamilton, J.D., and Seaworth, B.J. (1985). Transmission of latent cytomegalovirus in a murine kidney tissue transplantation model. Transplantation 39, 290-296.
17. Ibanez, C.E., Schrier, R., Ghazal, P., Wiley, C., and Nelson, J.A. (1991). Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65, 6581-6588.
18. Jordan, M.C., and Mar, V.L. (1982). Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus. J. Clin. Invest. 70, 762-768.
19. Kieff, E. (1996). Epstein-Barr virus and its replication. In Fields Virology, B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Philadelphia: Lippincott-Raven Publishers), pp. 2343-2396.
20. Koffron, A.J., Mueller, K.H., Kaufman, D.B., Stuart, F.P., Patterson, B., and Abecassis, M.I. (1995). Direct evidence using in situ polymerase chain reaction that the endothelial cell and T-lymphocyte harbor latent murine cytomegalovirus. Scand. J. Inf. Dis. (Suppl.) 99, 612.
21. Kondo, K., Kaneshima, H., and Mocarski, E.S. (1994). Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 91, 11879-11883.
22. Kondo, K., Xu, J., and Mocarski, E.S. (1996). Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc. Natl. Acad. Sci. USA 93, 11137-11142.
23. Lönnqvist, B., Ringden, O., Wahren, B., Gahrton, G., and Lundgren, G. (1984). Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease. Transplantation 38, 465-468.
24. Maciejewski, J.P., Bruening, E.E., Donahue, R.E., Mocarski, E.S., Young, N.S., and St. Jeor, S.C. (1992). Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80, 170-178.
25. Mandanas, R.A., Saez, R.A., Selby, G.B., and Confer, D.L. (1996). Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy. Am. J. Hematol. 51, 104-111.
26. Matloubian, M., Kolhekar, S.R., Somasundaram, T., Ahmed, R. (1993). Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 67, 7340-7349.
27. Melnick, J.L., Adam, E., and DeBakey, M.E. (1995). Cytomegalovirus and atherosclerosis. (Review). Bioessays 17, 899-903.
28. Mendelson, M., Monard, S., Sissons, P., and Sinclair, J. (1996). Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J. Gen. Virol. 77, 3099-3102.
29. Mercer, J.A., Wiley, C.A., and Spector, D.H. (1988). Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J. Virol. 62, 987-997.
30. Meyers, J.D. (1986). Infection in bone marrow transplant recipients. (Review). Am. J. Med. 81, 27-38.
31. Minton, E.J., Tysoe, C., Sinclair, J.H., and Sissons, J.G. (1994). Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68, 4017-4021.
32. Movassagh M., Gozlan, J., Senechal, B., Baillou, C., Petit, J.C., and Lemoine, F.M. (1996). Direct infection of CD34+ progenitor cells by human cytomegalovirus: evidence for inhibition of hematopoiesis and viral replication. Blood 88, 1277-1283.
33. Myerson, D., Hackman, R.C., Nelson, J.A., Ward, D.C., and McDougall, J.K. (1984). Widespread presence of histologically occult cytomegalovirus. Hum. Pathol. 15, 430-439.
34. Olding, L.B., Jensen, F.C., and Oldstone, M.B. (1975). Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction. J. Exp. Med. 141, 561-572.
35. Pollock, J.L., Presti, R.M., Paetzold S., Virgin H.W., IV. (1997). Latent murine cytomegalovirus infection in macrophages. Virology 227, 168-179.
36. Reddehase, M.J., Balthesen, M., Rapp, M., Jonjic, S., Pavic, I., and Koszinowski, U.H. (1994). The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J. Exp. Med. 179, 185-193.
37. Rettig, M.B., Ma, H.J., Vesico, R.A., Pold, M., Schiller, G., Belson, D., Savage, A., Nishikubo, C., Wu, C., Fraser, J., Said, J.W., and Berenson, J.R. (1997). Kaposi's Sarcoma-associated herpesvirus Infection of bone marrow dendritic cells from multiple myeloma patients. Science 276, 1851-1854.
38. Rice, G.P., Schrier, R.D., Oldstone, M.B. (1984) Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc. Natl. Acad. Sci. USA 81, 6134-6138
39. Roizman, B., and Sears, A.E. (1996). Herpes simplex virus and its replication. In Fields Virology, B.N. Fields, D.M. Knipe, P. Howley, ed. (Philadelphia: Lippincott-Raven Publishers), pp. 2231-2296.
40. Sallusto, F., and Lanzavecchia, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109-1118.
41. Schmader, K.E., Rahija, R., Porter, K.R., Daley, G., and Hamilton, J.D. (1992). Aging and reactivation of latent murine cytomegalovirus. J. Inf. Dis. 166, 1403-1407.
42. Schrier, R.D., Nelson, J.A., and Oldstone, M.B. (1985). Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science 230, 1048-1051.
43. Schrier, R.D., McCutchan, J.A., Venable, J.C., Nelson, J.A., and Wiley, C.A. (1990). T-cell-induced expression of human immunodeficiency virus in macrophages. J. Virol. 64, 3280-3288.
44. Simmons, P., Kaushansky, K., and Torok-Storb, B. (1990). Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc. Natl. Acad. Sci. USA 87, 1386-1390.
45. Sinzger, C., Plachter, B., Stenglein, S., and Jahn, G. (1993). Immunohistochemical detection of viral antigens in smooth muscle, stromal, and epithelial cells from acute human cytomegalovirus gastritis. J. Inf. Dis. 167, 1427-1432.
46. Sinzger, C., Plachter, B., Grefte, A., The, T.H., Jahn, G. (1996). Tissue macrophages are infected by human cytomegalovirus in vivo. J. Inf. Dis. 173, 240-245.
47. Söderberg, C., Larsson, S., Bergstedt-Lindqvist, S., and Möller, E. (1993). Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J. Virol. 67, 3166-3175.
48. Söderberg, C., Larsson, S., Rozell, B.L., Sumitran-Karuppan, S., Ljungman, P., and Möller, E. (1996). Cytomegalovirus-induced CD13-specific autoimmunity - a possible cause of chronic graft-vs-host disease. Transplantation 61, 600-609.
49. Stenberg, R.M., Depto, A.S., Fortney, J., and Nelson, J.A. (1989). Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J. Virol. 63, 2699-2708.
50. Taylor-Wiedeman, J., Sissons, P., Borysiewicz, L.K., and Sinclair, J.H. (1991). Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72, 2059-2064.
51. Stoddart, C.A., Cardin, R.D., Boname, J.M., Manning, W.C., Abenes, G.B., Mocarski, E.S. (1994). Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol. 68, 6243-6253.
52. Taylor-Wiedeman, J., Sissons, P., and Sinclair, J. (1994). Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68, 1597-1604.
53. Tegtmeier, G.E. (1989). Posttransfusion cytomegalovirus infections. Arch. Pathol. Lab. Med. 113, 236-245.
54. Torok-Storb, B., Simmons, P., Khaira, D., Stachel, D., and Myerson, D. (1992). Cytomegalovirus and marrow function. Ann. Hematol. 64, Suppl. A 128-131.
55. van den Berg, A.P., Klompmaker, I.J., Haagsma, E.B., Peeters, P.M., Meerman, L., Verwer, R., The, T.H., and Slooff, M.J. (1996). Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection. Clin. Transpl. 10, 224-231.
56. von Laer, D., Meyer-Koenig, U., Serr, A., Finke, J., Kanz, L., Fauser, A.A., Neumann-Haefelin, D., Brugger, W., and Hufert, F.T. (1995a). Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow. Blood 86, 4086-4090.
57. von Laer, D., Serr, A., Meyer-Konig, U., Kirste, G., Hufert, F.T., and Haller, O. (1995b). Human cytomegalovirus im mediate early and late transcripts are expressed in all major leukocyte populations in vivo. J. Inf. Dis. 172, 365-370.
58. Yagyu, K., van Breda Vriesman, P.J., Duijvestijn, A.M., Bruggeman, C.A, and Steinhoff, G. (1993). Reactivation of cytomegalovirus with acute rejection and cytomegalovirus infection with obliterative bronchiolitis in rat lung allografts. Transpl. Proc. 25, 1152-1154.
59. Zhou, Y.F., Leon, M.B., Waclawiw, M.A., Popma, J.J, Yu, Z.X., Finkel, T., and Epstein, S.E. (1996). Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. NEJM 335, 624-630.